Halaven(tm)

HATFIELD, England, May 25, 2011 - Halaven(TM) Black Triangle Drug (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease is launched today in the United Kingdom.